Characterization of gut microbiomes in nonalcoholic steatohepatitis (NASH) patients: A connection between endogenous alcohol and NASH

Nonalcoholic steatohepatitis (NASH) is a serious liver disease associated with obesity. Characterized by metabolic syndrome, hepatic steatosis, and liver inflammation, NASH is believed to be under the influence of the gut microflora. Here, the composition of gut bacterial communities of NASH, obese, and healthy children was determined by 16S ribosomal RNA pyrosequencing. In addition, peripheral blood ethanol was analyzed to monitor endogenous ethanol production of patients and healthy controls. UniFrac‐based principle coordinates analysis indicated that most of the microbiome samples clustered by disease status. Each group was associated with a unique pattern of enterotypes. Differences were abundant at phylum, family, and genus levels between healthy subjects and obese patients (with or without NASH), and relatively fewer differences were observed between obese and the NASH microbiomes. Among those taxa with greater than 1% representation in any of the disease groups, Proteobacteria, Enterobacteriaceae, and Escherichia were the only phylum, family and genus types exhibiting significant difference between obese and NASH microbiomes. Similar blood‐ethanol concentrations were observed between healthy subjects and obese non‐NASH patients, but NASH patients exhibited significantly elevated blood ethanol levels. Conclusions: The increased abundance of alcohol‐producing bacteria in NASH microbiomes, elevated blood‐ethanol concentration in NASH patients, and the well‐established role of alcohol metabolism in oxidative stress and, consequently, liver inflammation suggest a role for alcohol‐producing microbiota in the pathogenesis of NASH. We postulate that the distinct composition of the gut microbiome among NASH, obese, and healthy controls could offer a target for intervention or a marker for disease. (HEPATOLOGY 2013)

[1]  S. Bischoff,et al.  Nutrition, Intestinal Permeability, and Blood Ethanol Levels Are Altered in Patients with Nonalcoholic Fatty Liver Disease (NAFLD) , 2012, Digestive Diseases and Sciences.

[2]  Robert D. Stedtfeld,et al.  In-feed antibiotic effects on the swine intestinal microbiome , 2012, Proceedings of the National Academy of Sciences.

[3]  Richard A. Flavell,et al.  Inflammasome-mediated dysbiosis regulates progression of NAFLD and obesity , 2012, Nature.

[4]  J. Stockman,et al.  Metabolic Syndrome and Altered Gut Microbiota in Mice Lacking Toll-Like Receptor 5 , 2012 .

[5]  J. Heimbach,et al.  Frequency and outcomes of liver transplantation for nonalcoholic steatohepatitis in the United States. , 2011, Gastroenterology.

[6]  A. Lugea,et al.  Synergistic steatohepatitis by moderate obesity and alcohol in mice despite increased adiponectin and p-AMPK. , 2011, Journal of hepatology.

[7]  A. Baranova,et al.  Systematic review: the epidemiology and natural history of non‐alcoholic fatty liver disease and non‐alcoholic steatohepatitis in adults , 2011, Alimentary pharmacology & therapeutics.

[8]  M. Stepanova,et al.  Changes in the prevalence of the most common causes of chronic liver diseases in the United States from 1988 to 2008. , 2011, Clinical gastroenterology and hepatology : the official clinical practice journal of the American Gastroenterological Association.

[9]  P. Bork,et al.  Enterotypes of the human gut microbiome , 2011, Nature.

[10]  A. Fodor,et al.  Association between composition of the human gastrointestinal microbiome and development of fatty liver with choline deficiency. , 2011, Gastroenterology.

[11]  Joel Z Stengel,et al.  Prevalence of nonalcoholic fatty liver disease and nonalcoholic steatohepatitis among a largely middle-aged population utilizing ultrasound and liver biopsy: a prospective study. , 2011, Gastroenterology.

[12]  M. Greene,et al.  PKCδ Is Activated in a Dietary Model of Steatohepatitis and Regulates Endoplasmic Reticulum Stress and Cell Death* , 2010, The Journal of Biological Chemistry.

[13]  H. Tilg,et al.  Anti-inflammatory effects of excessive weight loss: potent suppression of adipose interleukin 6 and tumour necrosis factor α expression , 2010, Gut.

[14]  William A. Walters,et al.  QIIME allows analysis of high-throughput community sequencing data , 2010, Nature Methods.

[15]  N. Nowak,et al.  Role of Alcohol Metabolism in Non-Alcoholic Steatohepatitis , 2010, PloS one.

[16]  E. Zoetendal,et al.  The environment within: how gut microbiota may influence metabolism and body composition , 2010, Diabetologia.

[17]  G. La Torre,et al.  Increased intestinal permeability and tight junction alterations in nonalcoholic fatty liver disease , 2009, Hepatology.

[18]  Alexander Pertsemlidis,et al.  Genetic variation in PNPLA3 confers susceptibility to nonalcoholic fatty liver disease , 2008, Nature Genetics.

[19]  J. Crespo,et al.  Lipopolysaccharide-Binding Protein Plasma Levels and Liver TNF-Alpha Gene Expression in Obese Patients: Evidence for the Potential Role of Endotoxin in the Pathogenesis of Non-Alcoholic Steatohepatitis , 2007, Obesity surgery.

[20]  P. Adegboyega,et al.  Toll-like receptor-4 signaling and Kupffer cells play pivotal roles in the pathogenesis of non-alcoholic steatohepatitis. , 2007, Journal of hepatology.

[21]  Diego Matteuzzi,et al.  Kinetics and Metabolism of Bifidobacterium adolescentis MB 239 Growing on Glucose, Galactose, Lactose, and Galactooligosaccharides , 2007, Applied and Environmental Microbiology.

[22]  E. Mardis,et al.  An obesity-associated gut microbiome with increased capacity for energy harvest , 2006, Nature.

[23]  M. Pop,et al.  Metagenomic Analysis of the Human Distal Gut Microbiome , 2006, Science.

[24]  O. Cummings,et al.  Design and validation of a histological scoring system for nonalcoholic fatty liver disease , 2005, Hepatology.

[25]  G. Huffnagle,et al.  Does the microbiota regulate immune responses outside the gut? , 2004, Trends in microbiology.

[26]  R. Rao,et al.  Recent Advances in Alcoholic Liver Disease I. Role of intestinal permeability and endotoxemia in alcoholic liver disease. , 2004, American journal of physiology. Gastrointestinal and liver physiology.

[27]  Ruiting Lan,et al.  Escherichia coli in disguise: molecular origins of Shigella. , 2002, Microbes and infection.

[28]  E. Fries,et al.  Development and reproducibility of a brief food frequency questionnaire for assessing the fat, fiber, and fruit and vegetable intakes of rural adolescents. , 2001, Journal of the American Dietetic Association.

[29]  T. Sarkola,et al.  Effect of 4-methylpyrazole on endogenous plasma ethanol and methanol levels in humans. , 2001, Alcoholism, clinical and experimental research.

[30]  T. Risby,et al.  Increased gastrointestinal ethanol production in obese mice: implications for fatty liver disease pathogenesis. , 2000, Gastroenterology.

[31]  C. Lieber.  Microsomal ethanol-oxidizing system (MEOS): the first 30 years (1968-1998)--a review. , 1999, Alcoholism, clinical and experimental research.

[32]  T. Kumazawa,et al.  Ultra-sensitive method for determination of ethanol in whole blood by headspace capillary gas chromatography with cryogenic oven trapping. , 1999, Journal of chromatography. B, Biomedical sciences and applications.

[33]  C. Day,et al.  Steatohepatitis: a tale of two "hits"? , 1998, Gastroenterology.

[34]  D. Pessayre,et al.  Steatohepatitis-inducing drugs cause mitochondrial dysfunction and lipid peroxidation in rat hepatocytes. , 1998, Gastroenterology.

[35]  G. Brandi,et al.  Drinking habits as cofactors of risk for alcohol induced liver damage , 1997, Gut.

[36]  M. Säemann,et al.  n‐Butyrate downregulates the stimulatory function of peripheral blood‐derived antigen‐presenting cells: a potential mechanism for modulating T‐cell responses by short‐chain fatty acids , 1997, Immunology.

[37]  A. Paton,et al.  The risk of alcohol. , 1993, Addiction.

[38]  W. Maret,et al.  Extrahepatic, differential expression of four classes of human alcohol dehydrogenase. , 1993, Biochemical and biophysical research communications.

[39]  D. Clark,et al.  The fermentation pathways of Escherichia coli. , 1989, FEMS microbiology reviews.

[40]  M. Basta,et al.  Studies of metabolites in diarrheal stool specimens containing Shigella species by frequency-pulsed electron capture gas-liquid chromatography , 1985, Journal of clinical microbiology.

[41]  J. Ludwig,et al.  Nonalcoholic steatohepatitis: Mayo Clinic experiences with a hitherto unnamed disease. , 1980, Mayo Clinic proceedings.

[42]  K. Guire,et al.  Capacity of the colon in children. , 1979, AJR. American journal of roentgenology.

[43]  R. McCallum,et al.  Growth yields and fermentation balance of Bacteroides fragilis cultured in glucose-enriched medium , 1979, Journal of bacteriology.

[44]  J. Zeikus,et al.  Fermentation of cellulose and cellobiose by Clostridium thermocellum in the absence of Methanobacterium thermoautotrophicum , 1977, Applied and environmental microbiology.

[45]  R. Blomstrand.  Observations of the formation of ethanol in the intestinal tract in man. , 1971, Life sciences. Pt. 2: Biochemistry, general and molecular biology.

[46]  M. Gibbs,et al.  Anaerobic dissimilation of glucose-C14 by Escherichia coli. , 1961, Journal of bacteriology.

[47]  E. Dawes,et al.  The formation of ethanol in Escherichia coli. , 1956, Biochimica et biophysica acta.

[48]  J. L. Stokes.  FERMENTATION OF GLUCOSE BY SUSPENSIONS OF ESCHERICHIA COLI , 1949, Journal of bacteriology.